Provided by Tiger Trade Technology Pte. Ltd.

Abivax S.A.

106.99
+4.764.66%
Post-market: 106.990.00000.00%19:42 EDT
Volume:1.15M
Turnover:122.39M
Market Cap:9.31B
PE:-20.51
High:107.60
Open:104.59
Low:104.15
Close:102.23
52wk High:148.83
52wk Low:69.81
Shares:87.05M
Float Shares:76.46M
Volume Ratio:0.80
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.2168
EPS(LYR):-5.6758
ROE:-157.07%
ROA:-44.65%
PB:18.89
PE(LYR):-18.85

Loading ...

Movement Alert|Abivax S.A. Rises 5.12% in After-Hours Trading, Modest Rebound Following 40% Intraday Plunge on Phase 3 Cancer Safety Concerns

Market Focus
·
Jun 03

Top Midday Decliners

MT Newswires Live
·
Jun 03

Sector Update: Healthcare Stocks Fall in Afternoon Trading

MT Newswires Live
·
Jun 03

Abivax falls -40.3%

TIPRANKS
·
Jun 03

Abivax Faces Increasing Risk of Black Box Warning for Obefazimod, Wedbush Says

MT Newswires Live
·
Jun 02

Abivax price target lowered to $135 from $140 at Truist

TIPRANKS
·
Jun 02

Movement Alert|Abivax S.A. Falls 40.7% in Regular Trading, Phase 3 Trial Data Complicated by Cancer Cases Triggers Market Panic

Market Focus
·
Jun 02

Leerink Partners Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jun 02

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 02

Top Premarket Decliners

MT Newswires Live
·
Jun 02

Abivax Sa : Truist Securities Cuts Target Price to $135 From $140

THOMSON REUTERS
·
Jun 02

Morgan Stanley Lowers Price Target on Abivax to $132 From $145, Keeps Overweight Rating

MT Newswires Live
·
Jun 02

Movement Alert|Abivax S.A. Falls 30.12% in Pre-Market Trading, Phase 3 Trial Data Complicated by Cancer Cases Sparks Market Panic

Market Focus
·
Jun 02

Movement Alert|Abivax S.A. Declines 25.58% Overnight, Obefazimod Phase 3 Maintenance Trial Meets Primary Endpoint but Market Reacts Negatively

Market Focus
·
Jun 02

Abivax's Obefazimod Trial Meets Main Goal in Ulcerative Colitis; Shares Fall After Hours

MT Newswires Live
·
Jun 02

Movement Alert|Abivax S.A. Rises 31.08% in After-Hours Trading, Trading at $170.0

Market Focus
·
Jun 02

Abivax announces ABTECT trial meets primary, secondary endpoints

TIPRANKS
·
Jun 02

Abivax trading halted, news pending

TIPRANKS
·
Jun 02

NASDAQ TRADE HALT HALT NEWS PENDING AT 04:01 PM

Reuters
·
Jun 02

Analysts Are Bullish on These Healthcare Stocks: Biohaven Ltd. (BHVN), Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
May 30